The Pharmaceutical and Life Sciences industry is going through significant transformation and has unique real estate and workplace requirements. Why? Because 99% of pharmaceutical research fails. Antibiotics are losing effectiveness and new alternatives are required. Meanwhile, drug research has shifted from blockbuster to smart 'targeted' drugs. Simultaneously new technologies are transforming the idea of "what is a lab?". These dynamics mean that partnerships and collaboration are critical to drive innovation.
Recently two enlightening research studies have been conducted on this sector. The first global paper looks at the evolution of labs - miniaturisation, automation, artificial intelligence, virtual labs. The second APAC regional study looks at how the industry is embracing alternative workplace strategies. This session will include summary presentations of the research followed by an interactive discussion and a look at some of the most innovative new workplace solutions in the region.